Ultimovacs AB
Pioneering off-the-shelf TCR-NK cell therapies to cure solid cancers.
Oversigt
- 0
- Medarbejdere
- 5–10mio SEK
- Omsætning
- 2018
- Grundlagt
Nøglebeslutningstagere
Namir Hassan
CEO
Beskrivelse
Zelluna is a biotechnology company dedicated to pioneering novel cell therapies for the treatment of cancer patients. Their core mission is to eliminate solid cancers by developing T cell receptor (TCR) guided natural killer (NK) cell therapies, known as TCR-NK. This proprietary platform aims to ove...